Hua Q. Guo
Yinchuan, 750004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Research on the mechanism of CRMP4-mediated cytoskeletal actin polymerization in promoting invasive migration of stromal cells in endometriosis.
Journal: Journal of translational medicine
Published: October 27, 2025
HDAC3 Preserves the primordial follicle reserve by epigenetically suppressing ferroptosis in pregranulosa cells.
Journal: Cellular and molecular life sciences : CMLS
Published: August 11, 2025
HFTMSCs alleviate uterine fibrosis and restore fertility in intrauterine adhesion models.
Journal: Reproductive biology and endocrinology : RB&E
Published: July 28, 2025
Identify the therapeutic role and potential mechanism of α-cyperone in diminished ovarian reserve based on network pharmacology, molecular docking, Lip-MS and experimental validation.
Journal: Frontiers in pharmacology
Published: July 02, 2025
Biomimetic Nanoparticles Loaded With α-Cyperone Alleviating LPS-Induced Inflammation in KGN Cells by Activating Nrf2/HO-1 and Suppressing ROS.
Journal: Journal of biochemical and molecular toxicology
Published: February 07, 2025
Exosome-Derived lncRNA LIPE-AS1 Enhances Oocytes Maturation and Ameliorates Diminished Ovarian Reserve via the miR-330-5p/HDAC3 Axis.
Journal: Journal of biochemical and molecular toxicology
Published: January 15, 2025
Chronic stress causes ovarian fibrosis to impair female fertility in mice.
Journal: Cellular signalling
Published: May 12, 2024
PAI-1 siRNA-loaded biomimetic nanoparticles for ameliorating diminished ovarian reserve and inhibiting ovarian fibrosis.
Journal: European journal of pharmacology
Published: April 06, 2024
Stratified analysis of clinical pregnancy outcomes of sequential embryo transfer in frozen embryo transfer cycles based on different factors: a retrospective study.
Journal: BMC pregnancy and childbirth
Published: February 14, 2023
Value of the risk of ovarian malignancy algorithm index in predicting the recurrence of epithelial ovarian cancer.
Journal: Biomarkers in medicine
Published: September 05, 2022
Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.
Journal: Frontiers in oncology
Published: January 01, 2022
Last Updated: 09/26/2026